PhysioAssist

PhysioAssist is a French biotech company founded in 2012, based in Aix-en-Provence. The company specializes in the intersection of materials physics, signal processing, and life sciences to enhance patient quality of life, particularly in respiratory care. PhysioAssist is ISO-13485 certified, demonstrating its commitment to high medical device quality standards. The company develops and markets Simeox, an airway clearance device designed for patients with chronic respiratory disorders such as cystic fibrosis, bronchiectasis, and COPD. Simeox utilizes a unique intrapulmonary vibrating signal to improve mucus drainage, making it easier for patients to breathe. This device is suitable for use in both pulmonary rehabilitation centers and at home, promoting patient autonomy and ease of use. Additionally, PhysioAssist offers the Simeox Academy, an online training program for healthcare professionals to ensure effective use of their technology. In 2023, PhysioAssist was acquired by Inogen, expanding its global reach and preparing for FDA submission to enhance availability.

• Employees14
• Founded2012
• Annual Revenue$7000000
• Total Funding$7176115